Molnar-Institute - Pharma Technology Focus | Issue 99 | October 2020

DryLab's Empower-Automated AQbD Modeling Workflow

Empower Automated

www.DryLab.com

09/23/2020 13:43:57

Home | Under the microscope
In this issue
SHL Medical Company Insight
SHL Medical
Contents
Mimotopes
News
VEGA Australia
Covid-19 executive briefing by GlobalData
Wipotec
Nasal spray vaccine for Covid-19
Datwyler Company Insight
Datwyler
Covid-19 clinical trials continue to rise in Brazil
Biogazelle
AstraZeneca’s Phase I / II Covid-19 vaccine trial
Swiftpak
MTPA resumes screening and enrolment for global Phase III clinical trial of MT-1
Biesterfeld
The pharma industry briefing
From antitoxins to Covid-19 drugs: charting the history of antibody drugs
Quality control: pharma manufacturing inspections explained
Molnár-Institute Company Insight
Molnar-Institute
Oxytocin: the therapeutic potential of the ‘love hormone’
AI-enabled risk detection in pharma manufacturing
Dr. Paul Lohmann
Addressing the long-term effects of Covid-19
Eyes on the prize: the latest in retinitis pigmentosa gene therapies
HOF Sonderanlagenbau Company Insight
HOF Sonderanlagenbau
Breaking the taboo: disrupting the fertility sector
Neutralising the gluten threat: are we on the cusp of a coeliac disease breakthrough?
Nolato Company Insight
Nolato
Pharmacovigilance case intake: why the hesitation to automate?
Deals in brief powered by GlobalData
The key list powered by GlobalData
Zenatek
Global markets and indices powered by GlobalData
Macro-economic indicators (1 of 2) powered by GlobalData
Macro-economic indicators (2 of 2) powered by GlobalData
Events
Next issue